The burgeoning interest in GLP-3 agonists for glucose control has sparked considerable investigation into their mechanisms of action, particularly concerning their potential interaction with the RET pathway. While https://dillanzlcn210438.ka-blogs.com/92003557/glp-3-therapies-and-ret-signaling-a-detailed-analysis